<p>(a) Representative flow-cytometry histograms of surface marker molecules (green) EpCAM, NCAM1, FZD7, NTRK2, CD90, CD34, CD24, CD133, and their respective isotype controls (red) in HFK (19 weeks of gestation). (b) Summarizing bar graph of single marker staining in HFK (15–19 weeks of gestation). Each marker was tested on at least 3 independent samples. Data were calculated as average % of expressing cell±SD. Each marker was tested in 10 HFK.</p
<p>Antibodies against stem cell markers as CD29, CD44, CD73, CD90 and CD105 revealed an overall more...
<p>A) Cells were analyzed by flow cytometry for MSC surface markers CD29, Sca1; hematopoietic marker...
<p>(a) Representative flow cytometry of CD34, CD117, CD45, CD133, CD15, CD166, VEGF-R, HLA-DR, CD44,...
<p>(a) Representative dot plot graphs of EpCAM staining. Cells were gated in two groups: EpCAM negat...
<p>(a) Summarizing bar graph of single marker staining in HAK cells. Data were calculated as average...
<p>(a) Representative zebra graph of EpCAM staining and the subpopulation gating. EpCAM subpopulatio...
<p>Surface antigen profile analysis by flow cytometry for the derived MSC-like cells. (A) and (C) ar...
<p>Both SFCs and SFMSCs expressed similar surface markers, including CD90, CD44, CD105, and CD73. St...
<p>Representative FACS analyses shows that BM and HI-MSCs were positive for surface marker character...
<p>(A) Dot plot of gated living P2 NPCs followed by respective histograms of NPCs stained for the ce...
<p>(<b>A</b>) Isolated hMSCs were positive for surface markers CD146, CD29, CD147 and CD44, and nega...
<p>(a–j) Representative immunostaining of SIX2, NCAM1, FZD7, ACVR2B and NTRK2 in paraffin embedded s...
<p>(A1) hUCMSCs, bright field, x200; (A2) iHep, bright field, x200. (B) Demonstration of mesodermal ...
<p>(A) Expression of surface markers CD14, CD19, CD34, CD45, HLA-DR, CD73, CD90, CD105 (filled) with...
<p>(A) Expression of stem cell markers (EpCAM and CD133) in each fraction determined by FCM. (B) Bas...
<p>Antibodies against stem cell markers as CD29, CD44, CD73, CD90 and CD105 revealed an overall more...
<p>A) Cells were analyzed by flow cytometry for MSC surface markers CD29, Sca1; hematopoietic marker...
<p>(a) Representative flow cytometry of CD34, CD117, CD45, CD133, CD15, CD166, VEGF-R, HLA-DR, CD44,...
<p>(a) Representative dot plot graphs of EpCAM staining. Cells were gated in two groups: EpCAM negat...
<p>(a) Summarizing bar graph of single marker staining in HAK cells. Data were calculated as average...
<p>(a) Representative zebra graph of EpCAM staining and the subpopulation gating. EpCAM subpopulatio...
<p>Surface antigen profile analysis by flow cytometry for the derived MSC-like cells. (A) and (C) ar...
<p>Both SFCs and SFMSCs expressed similar surface markers, including CD90, CD44, CD105, and CD73. St...
<p>Representative FACS analyses shows that BM and HI-MSCs were positive for surface marker character...
<p>(A) Dot plot of gated living P2 NPCs followed by respective histograms of NPCs stained for the ce...
<p>(<b>A</b>) Isolated hMSCs were positive for surface markers CD146, CD29, CD147 and CD44, and nega...
<p>(a–j) Representative immunostaining of SIX2, NCAM1, FZD7, ACVR2B and NTRK2 in paraffin embedded s...
<p>(A1) hUCMSCs, bright field, x200; (A2) iHep, bright field, x200. (B) Demonstration of mesodermal ...
<p>(A) Expression of surface markers CD14, CD19, CD34, CD45, HLA-DR, CD73, CD90, CD105 (filled) with...
<p>(A) Expression of stem cell markers (EpCAM and CD133) in each fraction determined by FCM. (B) Bas...
<p>Antibodies against stem cell markers as CD29, CD44, CD73, CD90 and CD105 revealed an overall more...
<p>A) Cells were analyzed by flow cytometry for MSC surface markers CD29, Sca1; hematopoietic marker...
<p>(a) Representative flow cytometry of CD34, CD117, CD45, CD133, CD15, CD166, VEGF-R, HLA-DR, CD44,...